High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy.  That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading ->